Pathogenesis of vascular calcification in chronic kidney disease.
about
Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsPhosphate binders for preventing and treating bone disease in chronic kidney disease patientsBaroreflex dysfunction in chronic kidney diseaseModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsMICS, an easily ignored contributor to arterial calcification in CKD patients.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysisOptimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective.Klotho deficiency causes vascular calcification in chronic kidney disease.Prescribed dietary phosphate restriction and survival among hemodialysis patients.Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly womenEffects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients.Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells.Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients?Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis.Comparative Proteome Analysis of hAT-MSCs Isolated from Chronic Renal Failure Patients with Differences in Their Bone Turnover StatusVascular Calcification and Stone Disease: A New Look towards the Mechanism.Update on fibroblast growth factor 23 in chronic kidney disease.Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-HydroxylaseParicalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease.The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.Public health approach to addressing hyperphosphatemia among dialysis patients.Postprandial mineral metabolism and secondary hyperparathyroidism in early CKDMalnutrition, a new inducer for arterial calcification in hemodialysis patients?Causes and consequences of increased arterial stiffness in chronic kidney disease patients.Fetuin-A and Ghrelin Levels in Children with End Stage Renal Disease and the Effect of a Single Hemodialysis Session on ThemVascular calcification and uremia: what do we know?Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.Pulse pressure and presence of coronary artery calcificationPharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failureEmerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate.Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.Treatment of osteoporosis in renal insufficiency.Phosphate overload accelerates vascular aging in uremic patients.The role of phosphate in kidney disease.Of nanobacteria, nanoparticles, biofilms and their role in health and disease: facts, fancy and future.Osteonectin (SPARC) Expression in Vascular Calcification: In Vitro and Ex Vivo Studies.Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient.Where is the link between mineral bone markers and cardiovascular disease in CKD?
P2860
Q24234036-D2639EF2-9BF7-40AB-99BF-02EB62EF84FAQ24244049-16D65319-4A5F-4590-8748-76E4B8ED08ACQ26770747-FD73DCA4-E06E-42C8-B983-1460D07559E1Q28074264-065E1B4D-E9CA-441B-B6B3-1DBD4DB69244Q30249410-15F46DE5-13FE-419F-B12C-738C06AD47A0Q33932297-02C9A510-0A4A-47B9-939E-FD85364C3BB1Q34415635-251F6ECA-652A-4E58-B477-A5BCC164C415Q34457281-7E5944F3-5C24-49E3-9809-FB3B856B84F7Q34858005-2588EFE6-40AA-4439-90A7-462C6D9ED054Q34936957-F7405AFD-86FF-47EF-88F2-AEE90F76658DQ35055927-023C6C76-F684-4113-A39D-1DC702148F8DQ35107539-F458E6A7-6B48-4572-9F02-0A9572E657EFQ35154864-76B15607-891B-4312-ADC0-A1CB4C557DA9Q35669317-90F5803D-C9F3-47A6-9EF3-6CE2417E3389Q35843651-661EF261-4D16-4AAE-8094-9A331B1CEF0CQ35848058-FCAE819F-0305-4CFF-9C1A-F4E9717E5B9EQ36210285-DC777DD7-F28E-4A7D-8FD1-F32095540F20Q36255981-4C167AB1-D3AD-4C71-8D30-9C229C5DB709Q36428517-022A5C89-D810-4FA9-8D54-BA026E76C8F7Q36613869-612906EF-DFC3-45B2-8104-C59C3CAB075FQ36667038-BCEEC889-03C5-4AE6-B6E4-DCFB550EE9A0Q36667209-1C7825AC-6882-4287-AA1E-0EFAE1A8A771Q36716013-954CD6D8-8B73-4491-8BC1-6B62B47A1742Q36765398-7A0BEB66-F167-43A7-88D2-4624EF32A46EQ36929194-625CB93C-EFD4-4A76-861C-ED571DAA731CQ37018450-D8FAD3F1-1CE6-425D-AD73-5D3A26A299F5Q37075732-B1CF2CD7-AD3D-4247-91AD-5D5FF2111CB5Q37087856-5E4016C7-1CD9-470A-8CB4-E32580D377E6Q37099010-20B9DF60-BC5E-42F7-93BA-C0FEB3A08BEAQ37101624-15E53DAC-EB1A-462F-97E0-6748F8AB5B08Q37123402-B936D5CD-1F66-4849-A2B3-76658D3F171CQ38049170-8B79DBAF-A1AA-4A4D-B81E-5776FBE9A15AQ38253227-2025213B-580C-4D12-976B-ADE3D0BD3844Q38335645-3E9BD9E4-38A4-439D-AE3D-4D1D55745625Q38605311-3EE88CC8-22AF-4A77-97C9-DB6D21A3311FQ38793054-B902414C-68D2-4EFA-B260-3B245D1B9BCEQ39200253-62ADEFB6-4BE9-4F41-88E2-82ED8D303935Q39658458-EBFA1773-F6EA-4F39-9B1D-A0DD09AC4255Q40319543-6B718751-CFBD-422A-815B-78CE9D867CDCQ41880565-37FFBDF2-95FA-4393-9D41-BDB8256A4DA3
P2860
Pathogenesis of vascular calcification in chronic kidney disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pathogenesis of vascular calcification in chronic kidney disease.
@ast
Pathogenesis of vascular calcification in chronic kidney disease.
@en
type
label
Pathogenesis of vascular calcification in chronic kidney disease.
@ast
Pathogenesis of vascular calcification in chronic kidney disease.
@en
prefLabel
Pathogenesis of vascular calcification in chronic kidney disease.
@ast
Pathogenesis of vascular calcification in chronic kidney disease.
@en
P1433
P1476
Pathogenesis of vascular calcification in chronic kidney disease
@en
P2093
Diego Brancaccio
Eduardo Slatopolsky
P304
P356
10.1111/J.1523-1755.2005.00421.X
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1007398621